Genevieve’s Dream™
A CBGa led mission brand rooted in family, compassion and daily balance, with day and night support concepts.
Global Cannabinoid Research Center (GCRC)
GCRC holds a portfolio of cannabinoid and plant based wellness brands. Researcher® leads, and every brand has one clear purpose, audience and development path.
Products shown are formulation concepts in development unless marked otherwise. Nothing on this page is offered for sale yet.
Researcher® teaches the system before it sells the product. It is GCRC's public voice for endocannabinoid system education, cannabinoid variety and disciplined consumer communication.
The endocannabinoid system (ECS) is a signaling network found throughout the body that helps regulate many everyday functions. Researcher® is built around explaining that system in plain language and around the variety of cannabinoids the hemp plant offers, including acidic and minor cannabinoids. ECS Balance Control™ is the education framework behind the brand.
Daily soft gel and tincture concepts built for balance, consistency and cannabinoid variety.
Concepts focused on the acidic cannabinoids CBGa, CBDa and CBCa, starting where the plant starts.
Support beyond THC and CBD alone, with clear education on why a broader cannabinoid mix matters.
Measured oil, tincture, soft gel and oral syringe concepts for serious cannabinoid users.
Zero THC support for when the system needs balance instead of more intensity.
Relaxation Recovery® is GCRC's brand for THC tolerance education, zero THC support concepts and recovery routines. It does not argue with THC users. It gives the endocannabinoid system another conversation to work with.
A no THC daily tincture concept for people working on tolerance and responsiveness.
Simple capsules for a steady daily ECS support routine.
An evening concept focused on calm and preparing for rest.
Shelf ready education on THC tolerance, ECS support and why zero THC can still matter.
This is the proposed product architecture. Product claims about tolerance or receptor function are published only with supporting evidence.
A cannabinoid free brand in development for education around cannabinoid hyperemesis syndrome (CHS) and gastrointestinal comfort.
Cannabinoid hyperemesis syndrome is a condition linked to long term, heavy cannabis use. It is marked by repeated cycles of severe nausea and vomiting. Anyone who thinks they may have CHS should speak with a healthcare professional. Thermonoids® education is designed to support that conversation, not replace it.
Thermonoids® products are in development. They are not a proven treatment for CHS or any condition, and no clinical validation is implied. Topical use and formulation details are published for each product once confirmed.
Each brand carries a distinct direction. Dedicated pages for these brands are coming soon.
A CBGa led mission brand rooted in family, compassion and daily balance, with day and night support concepts.
Plant forward topical and wellness formats designed for daily skin and body care routines.
A phyto based support brand in development at GCRC, rooted in the center's work on plant health.
Prevent®, Genevex®, Indole-A™, NANO® and NANO CFP® are prototype concepts created for preclinical research. They sit in their own section with their own rules.
Researcher® is the lead brand. It focuses on endocannabinoid system education, acidic cannabinoids and minor cannabinoid variety, with ECS Balance, The Foundation and Minor Cannabinoid Complex as its product platforms.
Not yet. The products shown are formulation concepts in development. Purchasing will open only when finished products and fulfillment are ready.
Yes. GCRC invites manufacturing, distribution and retail partners to discuss available brands. Brand availability is shown on the Partnerships page.
They are prototype concepts for preclinical research, not consumer products and not approved medicines. They are presented separately on the Pharmaceutical Trademarks page.
Partners, clients and research collaborators, tell us what you are building.